Roche Holding AG ROG

Updated: 12 Jun 2026

SIX Swiss Exchange | Biotech | Pharmaceuticals and diagnostics

No signal published yet

We already track Roche Holding AG and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Roche Holding AG free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
SIX Swiss Exchange
Type
Biotech
Sector
Pharmaceuticals and diagnostics
We're already tracking Roche Holding AG — here are the latest events we've registered

Recent News

  • On June 11, 2026, Roche announced that the U.S. FDA granted priority review for Tecentriq in treating a specific type of stage III colon cancer. Earlier in June, the company entered a collaboration agreement with Nurix Therapeutics worth up to $2.3 billion to co-develop new therapies for B-cell malignancies and autoimmune diseases.

What Firelda Watch includes for Roche Holding AG

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Roche Holding AG will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Medicover
MCOV B
HOLD
Bioarctic
BIOA B
BUY
Recipharm
RECI B
NEUTRAL
Viatris Inc.
VTRS
HOLD
Xbrane Biopharma AB (publ)
XBRANE
HOLD

Biotech

More companies in this sector

Want to follow Roche Holding AG? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Roche Holding AG free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Roche Holding AG ROG
Roche Holding AG — follow and we'll monitor it
Follow Roche Holding AG free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.